Science in Sport plc (SIS.L)
- Previous Close
33.30 - Open
33.16 - Bid 33.00 x --
- Ask 34.00 x --
- Day's Range
33.10 - 34.00 - 52 Week Range
15.50 - 34.00 - Volume
434,311 - Avg. Volume
325,591 - Market Cap (intraday)
77.126M - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.02 - Earnings Date Apr 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes and sports enthusiasts in the United Kingdom, the United States, Europe, and internationally. It operates through the Science in Sport and PhD Nutrition segments. The company offers energy products, including bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; and vitamins and supplements under the Science in Sport brand. It also provides diet protein products; Smart high protein, low sugar products comprising food, bars, and snacks, such as Smart bar on-the-go protein hit and Smart protein powder for cooking; Life products, which include Reset nighttime formula, Mind product, and Complete high protein, low sugar, plant-based meal solution; and Performance supplements under the PhD brand. It sells its products through the scienceinsport.com and PhD.com digital platforms, third-party online sites, and retail distribution, including supermarkets and high street chains, and specialist sports retailers. Science in Sport plc was founded in 1992 and is based in London, the United Kingdom.
www.scienceinsport.com208
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SIS.L
View MorePerformance Overview: SIS.L
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SIS.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SIS.L
View MoreValuation Measures
Market Cap
77.13M
Enterprise Value
91.83M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.30
Price/Book (mrq)
2.35
Enterprise Value/Revenue
1.77
Enterprise Value/EBITDA
42.69
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.14%
Return on Assets (ttm)
-3.29%
Return on Equity (ttm)
-15.33%
Revenue (ttm)
51.88M
Net Income Avi to Common (ttm)
-4.74M
Diluted EPS (ttm)
-0.02
Balance Sheet and Cash Flow
Total Cash (mrq)
1.97M
Total Debt/Equity (mrq)
50.83%
Levered Free Cash Flow (ttm)
585.38k